Reduced adipose tissue development (lipodystrophy) can lead to almost all the features of metabolic syndrome [56], and a subset of lipodystrophy patients exhibit reduced plasma adiponectin and numerous metabolic complications [57]. The gene discussed is ADIPOQ; the disease is lipodystrophy.